Theriva Biologics Inc (TOVX): Already tested the 200day in after marke...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	319
Posts	15853
Boards Moderated	0
Alias Born	01/02/2010

Citrati

Re: Jumpinjackas post# 7666

Wednesday, 11/01/2017 11:51:52 PM

Wednesday, November 01, 2017 11:51:52 PM

Already tested the 200day in after market.
This is why even solid science can be volatile and test ones sanity. FDA in bios is like Fed in metals.
Still a great future.
Have a plan. Work the plan. Collect green along the way.
SYN

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TOVX News

Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 01:10:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:10:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:07:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:01:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:00:21 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:00:19 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:15:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 11:10:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 10:05:12 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 10:06:35 AM
Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 08/16/2023 09:24:26 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/15/2023 01:53:41 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/14/2023 09:11:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 08:30:38 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 01:03:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 12:10:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 01:22:02 PM
Another Biotech Stealing The Premarket Spotlight • AllPennyStocks.com • 06/28/2023 02:15:00 PM

More TOVX News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover